Free Trial
→ Goldman Sachs just told you what to buy (most people missed it) (From Behind the Markets) (Ad)tc pixel Free SBFMW Stock Alerts

Sunshine Biopharma (SBFMW) Competitors

Sunshine Biopharma logo
$0.02 0.00 (0.00%)
As of 09:37 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

SBFMW vs. AIMDW, ALVOW, ARAV, ACABW, and BFRIW

Should you buy Sunshine Biopharma stock or one of its competitors? MarketBeat compares Sunshine Biopharma with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Sunshine Biopharma include Ainos (AIMDW), Alvotech (ALVOW), Aravive (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), and Biofrontera (BFRIW). These companies are all part of the "pharmaceutical products" industry.

How does Sunshine Biopharma compare to Ainos?

Ainos (NASDAQ:AIMDW) and Sunshine Biopharma (NASDAQ:SBFMW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, analyst recommendations, media sentiment, profitability, risk and earnings.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ainos$18.11KN/AN/AN/AN/A
Sunshine Biopharma$35.49MN/AN/AN/AN/A

In the previous week, Ainos and Ainos both had 2 articles in the media. Sunshine Biopharma's average media sentiment score of 1.45 beat Ainos' score of 0.93 indicating that Sunshine Biopharma is being referred to more favorably in the news media.

Company Overall Sentiment
Ainos Positive
Sunshine Biopharma Positive

Company Net Margins Return on Equity Return on Assets
AinosN/A N/A N/A
Sunshine Biopharma N/A N/A N/A

Summary

Sunshine Biopharma beats Ainos on 2 of the 2 factors compared between the two stocks.

How does Sunshine Biopharma compare to Alvotech?

Sunshine Biopharma (NASDAQ:SBFMW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, media sentiment, dividends, risk and analyst recommendations.

In the previous week, Sunshine Biopharma had 1 more articles in the media than Alvotech. MarketBeat recorded 2 mentions for Sunshine Biopharma and 1 mentions for Alvotech. Alvotech's average media sentiment score of 1.89 beat Sunshine Biopharma's score of 1.45 indicating that Alvotech is being referred to more favorably in the news media.

Company Overall Sentiment
Sunshine Biopharma Positive
Alvotech Very Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sunshine Biopharma$35.49MN/AN/AN/AN/A
Alvotech$586.32MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Sunshine BiopharmaN/A N/A N/A
Alvotech N/A N/A N/A

Summary

Alvotech beats Sunshine Biopharma on 2 of the 3 factors compared between the two stocks.

How does Sunshine Biopharma compare to Aravive?

Sunshine Biopharma (NASDAQ:SBFMW) and Aravive (NASDAQ:ARAV) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, dividends, earnings, institutional ownership, risk and profitability.

35.8% of Aravive shares are held by institutional investors. 60.4% of Aravive shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Company Net Margins Return on Equity Return on Assets
Sunshine BiopharmaN/A N/A N/A
Aravive N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sunshine Biopharma$35.49MN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

In the previous week, Sunshine Biopharma had 2 more articles in the media than Aravive. MarketBeat recorded 2 mentions for Sunshine Biopharma and 0 mentions for Aravive. Sunshine Biopharma's average media sentiment score of 1.45 beat Aravive's score of 0.00 indicating that Sunshine Biopharma is being referred to more favorably in the media.

Company Overall Sentiment
Sunshine Biopharma Positive
Aravive Neutral

Summary

Sunshine Biopharma beats Aravive on 3 of the 5 factors compared between the two stocks.

How does Sunshine Biopharma compare to Atlantic Coastal Acquisition Corp. II?

Sunshine Biopharma (NASDAQ:SBFMW) and Atlantic Coastal Acquisition Corp. II (NASDAQ:ACABW) are both pharmaceutical products companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, analyst recommendations, valuation, earnings, risk, institutional ownership, profitability and media sentiment.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sunshine Biopharma$35.49MN/AN/AN/AN/A
Atlantic Coastal Acquisition Corp. IIN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Sunshine BiopharmaN/A N/A N/A
Atlantic Coastal Acquisition Corp. II N/A N/A N/A

In the previous week, Sunshine Biopharma had 2 more articles in the media than Atlantic Coastal Acquisition Corp. II. MarketBeat recorded 2 mentions for Sunshine Biopharma and 0 mentions for Atlantic Coastal Acquisition Corp. II. Sunshine Biopharma's average media sentiment score of 1.45 beat Atlantic Coastal Acquisition Corp. II's score of 0.00 indicating that Sunshine Biopharma is being referred to more favorably in the media.

Company Overall Sentiment
Sunshine Biopharma Positive
Atlantic Coastal Acquisition Corp. II Neutral

Summary

Sunshine Biopharma beats Atlantic Coastal Acquisition Corp. II on 3 of the 3 factors compared between the two stocks.

How does Sunshine Biopharma compare to Biofrontera?

Biofrontera (NASDAQ:BFRIW) and Sunshine Biopharma (NASDAQ:SBFMW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, valuation, institutional ownership, earnings, analyst recommendations, dividends, profitability and media sentiment.

Company Net Margins Return on Equity Return on Assets
BiofronteraN/A N/A N/A
Sunshine Biopharma N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biofrontera$43.20MN/AN/AN/AN/A
Sunshine Biopharma$35.49MN/AN/AN/AN/A

In the previous week, Sunshine Biopharma had 1 more articles in the media than Biofrontera. MarketBeat recorded 2 mentions for Sunshine Biopharma and 1 mentions for Biofrontera. Biofrontera's average media sentiment score of 1.87 beat Sunshine Biopharma's score of 1.45 indicating that Biofrontera is being referred to more favorably in the media.

Company Overall Sentiment
Biofrontera Very Positive
Sunshine Biopharma Positive

Summary

Biofrontera beats Sunshine Biopharma on 2 of the 3 factors compared between the two stocks.

Get Sunshine Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for SBFMW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SBFMW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SBFMW vs. The Competition

Export
MetricSunshine BiopharmaDrug Manufacturers IndustryMedical SectorNASDAQ Exchange
Market CapN/A$2.40B$6.50B$11.90B
Dividend YieldN/A2.95%2.67%5.55%
P/E RatioN/A4.8624.5823.87
Price / SalesN/A1,640.61501.27107.19
Price / CashN/A10.1842.3656.09
Price / BookN/A10.2410.386.78
Net IncomeN/A$20.27B$3.56B$337.26M
7 Day PerformanceN/A0.98%-0.73%-0.55%
1 Month PerformanceN/A7.77%1.40%1.99%
1 Year PerformanceN/A17.98%20.64%24.17%

Sunshine Biopharma Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SBFMW
Sunshine Biopharma
N/A$0.03
flat		N/A-90.7%$0.00$35.49MN/A3
AIMDW
Ainos
N/A$0.11
-14.3%		N/A+32.4%$0.00$18.11KN/A40
ALVOW
Alvotech
N/A$0.24
-7.7%		N/A-88.5%$0.00$586.32MN/A4
ARAV
Aravive
N/A$0.04
flat		N/AN/A$0.00N/AN/A20
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.00
flat		N/AN/A$0.00N/AN/A15

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SBFMW) was last updated on 6/10/2026 by MarketBeat.com Staff.
From Our Partners
He Called NVIDIA at $1.10 – Now He Says, “SELL”
The analyst who called NVIDIA at $1.10 now says sell. According to Alexander Green, Chief Investment Strategis...
The Oxford Club | Sponsoredtc pixel
One hidden supplier shipped 5 billion parts to SpaceX
Most investors are focused on the historic $1.75 trillion SpaceX IPO expected around June 30. But there's a le...
Weiss Ratings | Sponsoredtc pixel
I was right about SpaceX
Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...
Brownstone Research | Sponsoredtc pixel
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...
Banyan Hill Publishing | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
The part that convinced me Joel is legit
Most trading gurus cite big win rates but won't let you verify them. Joel Peterson is different - his trade pl...
Crypto Swap Profits | Sponsoredtc pixel
“The unseen winner of the AI race” is not SpaceX
Marc Chaikin - the analyst who called Nvidia before its historic run - says a tech firm labeled 'the unseen wi...
Chaikin Analytics | Sponsoredtc pixel
In 30 days, you'll wish you'd read this email
A small power equipment company with $1.5 billion in orders is flying under the radar - but not for long. When...
Behind the Markets | Sponsoredtc pixel